En Es
Categories

Industry News

Global Medical Robotics Market to Reach USD 13.90 Billion by 2026

By HospiMedica International staff writers
10 Feb 2020

IllustrationThe global medical robotics market is projected to grow at a double-digit CAGR from 2019 to 2026 to reach USD 13.90 billion by 2026, driven by the increasing demand for minimally invasive surgery, rising prevalence of gynecology, urology and orthopedic disorders, increasing aging population, technological innovations, growing adoption of medical robots among the population and increasing clinical trials.

These are the latest findings of IQ4I Research and Consultancy Pvt. Ltd. (Karnataka, India), a global strategy, consulting and a market research firm.

Based on product, the surgical robotics segment accounted for the largest revenues of the medical robotics market in 2019 and is expected to grow at a low teen CAGR during the forecast period. The rehabilitation robotics segment is projected to grow in the high single-digit, while the hospital & pharmacy robotics segment is expected to record a mid-single digit CAGR during the forecast period.

Within the surgical robotics segment, instruments & accessories accounted for the largest revenues in 2019 and is expected to grow at a mid-teen CAGR during the forecast period. Systems is expected to record a double-digit CAGR, while services is projected to grow at a mid-teen CAGR during the forecast period. Within the rehabilitation robotics segment, assistive (cognitive) robots held the largest revenue share in 2019 and is expected to grow at a high single-digit CAGR during the forecast period. Exoskeleton robots is expected to record a high single-digit CAGR, while prosthetics robots is projected to grow at a mid-single digit CAGR during the forecast period. Within the hospital and pharmacy robotics segment, fill and pack robots accounted for the largest revenues in 2019 and is expected to grow at a mid-single digit CAGR during the forecast period. Pill dispensing robots is expected to record a low single-digit CAGR, while other robots is expected to grow at a mid-single-digit CAGR during the forecast period.

Based on application, the general and gastroenterology segment accounted for the largest revenues of the medical robotics market in 2019 and is expected to record a low-teen CAGR, while the neurosurgery segment is expected to grow exponentially during the forecast period.

Geographically, North America accounted for the largest revenues of the global medical robotics market in 2019 and is expected to grow at a low teen CAGR during the forecast period, mainly due to increased prevalence of chronic illness and lifestyle disorders, growing aging population, increase in healthcare expenditure, availability of surgical expertise, increase in research activities, steady number of product approvals and new product launches among the key market players, increased demand for assistive robots and adoption of new technologies in the region. The Asia-Pacific medical robotics market is projected to record a mid-teen CAGR during the forecast period, driven by high levels of healthcare expenditure, improving healthcare infrastructure and increasing government healthcare budgets, funds, growing acceptance of technological advancements, increasing aging population, rising awareness about medical robotics and growing healthcare awareness in the region’s emerging countries, such as India and China.

Related Links:
IQ4I Research and Consultancy Pvt. Ltd.



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

19 Feb 2020
New Artificial Intelligence Algorithm Boosts Quality of Brain Magnetic Resonance Imaging
 Researchers from the ICAI Group -Computational Intelligence and Image Analysis- of the University of Malaga {(UMA) Málaga, Spain) have designed a method that is capable of improving brain images obtained through magnetic resonance imaging using artificial intelligence (AI). The new model manages to increase image quality from low resolution to high resolution without distorting the patients' brain structures, using a deep learning artificial neural network - a model based on the functioning of the human brain - that "learns" this process.
Read More
17 Feb 2020
New System Combines Advanced Optical Imaging with AI Algorithm to Accurately Identify Brain Tumors
 Researchers from the NYU Grossman School of Medicine (New York, NY, USA) and the University of Michigan (Ann Arbor, MI, USA) have developed a novel method of combining advanced optical imaging with an artificial intelligence (AI) algorithm to produce accurate, real-time intraoperative diagnosis of brain tumors. The imaging technique, stimulated Raman histology (SRH), reveals tumor infiltration in human tissue by collecting scattered laser light, illuminating essential features not typically seen in standard histologic images. The microscopic images are then processed and analyzed with AI, allowing surgeons to see a predicted brain tumor diagnosis in less than three minutes. Using the same technology, after the resection, the surgeons can accurately detect and remove otherwise undetectable tumor.
Read More
04 Feb 2020
Patient Handling Equipment Market to Reach USD 12.6 Billion by 2024
 The global patient handling equipment market is projected to grow at a CAGR of 7.2% from USD 8.9 billion in 2019 to USD 12.6 billion by 2024, driven mainly by the rising geriatric population, high risk of injuries to caregivers during manual handling of patients, and regulations for ensuring the safety of healthcare personnel during manual lifting processes. However, continued difficulties in handling bariatric patients are expected to limit the market growth to some extent.
Read More
30 Jan 2020
Study Finds Most Healthcare Institutions Plan to Use AI and Develop Own AI Algorithm
 A new study of healthcare professionals has revealed that Artificial Intelligence (AI) is widely expected to drive important benefits across the health system, from increasing efficiency to improving patient outcomes, but may also be the key to making healthcare more human. AI’s benefits range from increasing the amount of time clinicians can spend with patients and on cross-care team collaboration to enhancing the ability to deliver preventative care.
Read More
30 Jan 2020
Quest Diagnostics Acquires Blueprint Genetics
 Quest Diagnostics (Secaucus, NJ, USA), a provider of diagnostic information services, has acquired Blueprint Genetics (Helsinki, Finland), a specialty genetic testing company with expertise in gene variant interpretation based on next generation sequencing (NGS) and proprietary bioinformatics. Together, Quest and Blueprint Genetics will broaden access to actionable insights in genetic and rare diseases, improving patient care and pharmaceutical drug research and development.
Read More
27 Jan 2020
JNJ Acquires Remaining Stake in Verb Surgical
 Johnson & Johnson (New Brunswick, N.J., USA) has acquired the remaining stake in Verb Surgical Inc. (Santa Clara, CA, USA), following a successful strategic collaboration with Verily, an Alphabet company. Verb Surgical's robotics and data science capabilities, combined with Johnson & Johnson's health care leadership and global reach, aim to make medical interventions smarter, less invasive and more personalized.
Read More
22 Jan 2020
Global Point of Care Testing (POCT) Market to Reach USD 46.7 Billion by 2024
 The global point of care testing (POCT) market is expected to surpass USD 37 billion by 2025, driven mainly by the migration of POCT from the hospital environment to a range of medical environments, including the workplace, home, disaster care and most recently, convenience clinics. POCT now appears to be headed for a bigger role in diagnosis and monitoring patient care. Additionally, growing awareness about early disease diagnosis and prevention has stimulated the demand for POCT for detecting cancer and infectious disease in the early stages. Moreover, the rising incidence of infectious diseases and chronic conditions, such as cardiovascular diseases and diabetes in the developing countries such as India and China, is stimulating the demand for POCT services.
Read More
16 Jan 2020
Radiomic Algorithm Predicts if Patient’s Cancer Can Return 10 Years After Treatment
 A new study by researchers at Penn Medicine (Philadelphia, PA, USA) has found that Magnetic Resonance Imaging (MRI) and an emerging field of medicine called radiomics — which uses algorithms to extract a large amount of features from medical images — could help to characterize the heterogeneity of cancer cells within a tumor and allow for a better understanding of the causes and progression of a person’s individual disease.
Read More
13 Jan 2020
PENTAX Medical Clears CE Mark for New AI-Assisted Polyp Detector
 PENTAX Medical (Tokyo, Japan) has cleared CE mark for DISCOVERY, its Artificial Intelligence (AI) assisted polyp detector designed to support endoscopists in finding potential polyps during a colorectal examination.
Read More
Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions